Company Filing History:
Years Active: 1985
Title: Klaus Gruber: Innovator in Transdermal Medication
Introduction
Klaus Gruber is a notable inventor based in Remagen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal medication.
Latest Patents
Klaus Gruber holds a patent for a transdermal medication that utilizes 2-(4-isobutylphenyl)-propionic acid. This innovative pharmaceutical formulation is designed for external administration and is created by dissolving the active ingredient in a mixture of C.sub.6-12 carboxylic acid triglycerides, glycerol monostearate-polyoxyethylene stearate mixture, and polyoxyethylene-fatty acid esters. The resulting cream is produced by stirring this solution with an aqueous phase while applying heat.
Career Highlights
Klaus Gruber is associated with Dolorgiet GmbH & Co. KG, where he has been instrumental in advancing pharmaceutical technologies. His work has focused on improving the efficacy and delivery of medications through innovative formulations.
Collaborations
Throughout his career, Klaus has collaborated with notable colleagues, including Manfred Lohner and Klaus Posselt. These partnerships have contributed to the development of effective pharmaceutical solutions.
Conclusion
Klaus Gruber's contributions to transdermal medication highlight his innovative spirit and dedication to improving healthcare. His work continues to influence the pharmaceutical industry and enhance patient care.